Skip to the page

Data / Form D filings / Spotlight Innovation, Inc.

Spotlight Innovation, Inc.: Form D filings

Spotlight Innovation, Inc., a pharmaceuticals company in West Des Moines, IA, filed 4 Form D notices with the SEC between 2014 and 2016. The latest, on December 6, 2016, reports $1.4 million sold of a $2.5 million offering to 17 investors.

Find out what Spotlight Innovation, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6750 Westown Parkway, Suite 200-226, West Des Moines, IA, 50266
Phone
(515) 274-9087
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Nevada
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1388486

The full lists. Form D filings in Iowa: 206 rows, $10.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 6, 2016New notice$2,500,000$1,382,000$1,118,00017Aug 31, 2016sec.gov
Nov 19, 2015New notice$850,000$0$850,0000Yet to occursec.gov
Jun 19, 2014New notice$41,418,000$41,418,000$00Yet to occursec.gov
Jan 28, 2014New notice$500,000$0$500,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
William PimExecutive Officer
Craig LangDirector
Cristopher GrunewaldExecutive Officer, Director
John KrohnDirector

Every Form D from the week of Dec 5, 2016 · All recent filings in Iowa · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Spotlight Innovation, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.